Clinical Trials
3 trialsNCT02403310 2022-10-03
A Study of Selinexor in Combination With Daunorubicin and Cytarabine for Untreated AML
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT05456048 2022-07-13
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
Nanfang Hospital, Southern Medical University
Completed
NCT01242774 2020-12-19
Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML)
Novartis
Phase 1 Completed